Loading company…
SeaLife Pharma, an Austrian biotech, develops antibiotics derived from marine organisms to treat resistant infections.
Founded in 2008 and headquartered in Austria, SeaLife Pharma GmbH researches antibiotics derived from microorganisms in extreme ocean environments, aimed at antibiotic-resistant pathogens. Its candidates are in laboratory testing and clinical trials, with some progressing to Phase II. Alexander Pretsch is CEO, and in March 2011 the company raised undisclosed amounts from tecnet equity.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in